Home/Filings/8-K/0001628280-26-001348
8-K//Current report

Vita Coco Company, Inc. 8-K

Accession 0001628280-26-001348

$COCOCIK 0001482981operating

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:20 PM ET

Size

198.6 KB

Accession

0001628280-26-001348

Research Summary

AI-generated summary of this filing

Updated

Vita Coco Appoints Director Shelley Broader; Names CCO Charles van Es

What Happened
Vita Coco (COCO) filed an 8-K reporting that on January 7, 2026 its Board increased from nine to ten directors and appointed Shelley Broader as a Class II director to fill the vacancy (serving until the end of Class II’s term at the next annual meeting). The company will determine and disclose Ms. Broader’s committee assignments later and will amend the 8-K when that information is available. The company said Ms. Broader will be paid under its non-employee director compensation policy and will enter into the company’s standard indemnification agreement. The filing also discloses a press release dated January 8, 2026 announcing the board appointment.

In addition, the Board appointed Charles van Es as Chief Commercial Officer effective January 1, 2026. In this role Mr. van Es will lead global commercial strategy and market development while continuing to oversee the U.S. market; the filing states there are no changes to his compensation as a result of the appointment.

Key Details

  • Board size increased from 9 to 10; Shelley Broader appointed as Class II director on January 7, 2026.
  • Ms. Broader will serve until the end of the Class II term at the next annual meeting; committee assignments pending and will be disclosed in an amendment.
  • Charles van Es named Chief Commercial Officer effective January 1, 2026, to lead global commercial strategy and market development; no change in his pay.
  • Ms. Broader has no arrangements or related-party transactions requiring disclosure; company will enter its standard indemnification agreement with her.

Why It Matters
These are governance and leadership updates that investors should note: the board has one new non-employee director (affecting oversight and voting composition through the next annual meeting) and the company has formalized the CCO role for commercial leadership. The lack of compensation change for Mr. van Es and the use of standard director pay and indemnification for Ms. Broader are factual items investors can monitor. The company will provide more detail once Ms. Broader’s committee assignments are set.